An LC–MS/MS Method for the Quantitation of Metabolites M9, M12, and M20 of Bexicaserin in Human Cerebrospinal Fluid
Biomedical Chromatography · 2026-02 · 40 (2)
DOI: 10.1002/bmc.70341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 05.01.2026. Verfasst von Raja Reddy Kallem und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Pharmacometrics, Lundbeck Pharmaceuticals LLC, Deerfield, Illinois, USA. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The investigational molecule bexicaserin is a highly selective 5‐HT 2C superagonist currently in Phase 3 clinical studies for the treatment of seizures associated with developmental and epileptic encephalopathies (DEEs). To facilitate its clinical development, a simple LC–MS/MS method was developed and validated for the quantitative estimation of its metabolites, M9, M12, and M20, in human cerebrospinal fluid (CSF). The sample preparation involves sample dilution extraction of metabolites and SIL‐IS internal standards from 25 μL of human CSF. The chromatographic separation of three metabolites was achieved on an Acquity HSS T3, C18 column using an 8.0‐min gradient program. The intraday and interday precision and accuracy for all three metabolites were well within the range of acceptable limits. Stability studies in CSF showed that metabolites were stable in the presence of bexicaserin on the bench for 24 h, in the auto‐sampler over 92 h, and extracted stability at 6°C for 48 h. Metabolites were stable in the presence of bexicaserin after three freeze–thaw cycles and long‐term storage at −20°C and −80°C for 41 days. This method has since been successfully applied in a clinical study for the quantitative estimation of metabolite concentrations in CSF from a clinical study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Pharmacometrics, Lundbeck Pharmaceuticals LLC, Deerfield, Illinois, USA.
- Nonclinical Development, Lundbeck Pharmaceuticals LLC, Deerfield, Illinois, USA.
- Delivery, York Bioanalytical Solutions (YBS), Cedar House, Northminster Business Park, Upper Poppleton, York, UK.
ORCID-Profile: Raja Reddy Kallem, Nuggehally R Srinivas
Zitieren
APA
Kallem, R. R., Chan, R., Yeager, M., Neal, K., Fletcher, K., & Srinivas, N. R. (2026). An LC–MS/MS Method for the Quantitation of Metabolites M9, M12, and M20 of Bexicaserin in Human Cerebrospinal Fluid. Biomedical Chromatography, 40(2). https://doi.org/10.1002/bmc.70341
Vancouver
Kallem RR, Chan R, Yeager M, Neal K, Fletcher K, Srinivas NR. An LC–MS/MS Method for the Quantitation of Metabolites M9, M12, and M20 of Bexicaserin in Human Cerebrospinal Fluid. Biomedical Chromatography. 2026;40(2). doi:10.1002/bmc.70341
BibTeX
@article{Kallem2026,
author = {Kallem, Raja Reddy and Chan, Rosa and Yeager, Maisy and Neal, Katie and Fletcher, Katharine and Srinivas, Nuggehally R},
title = {An LC–MS/MS Method for the Quantitation of Metabolites M9, M12, and M20 of Bexicaserin in Human Cerebrospinal Fluid},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {2},
doi = {10.1002/bmc.70341}
}
EUVIMED